Related references
Note: Only part of the references are listed.Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
Philippe Guilpain et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Reducing mortality from 2019-nCoV: host-directed therapies should be an option
Alimuddin Zumla et al.
LANCET (2020)
COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2
M. D. Willis et al.
JOURNAL OF NEUROLOGY (2020)
Why the immune system fails to mount an adaptive immune response to a COVID-19 infection
Pedram Ahmadpoor et al.
TRANSPLANT INTERNATIONAL (2020)
Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York
Sumit Mohan
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Acute kidney injury in patients hospitalized with COVID-19
Jamie S. Hirsch et al.
KIDNEY INTERNATIONAL (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Covid-19 and Kidney Transplantation
Enver Akalin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression
Fang Liu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
A single center observational study lb Check of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia
Federico Alberici et al.
KIDNEY INTERNATIONAL (2020)
Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506
Javier Carbajo-Lozoya et al.
VIRUS RESEARCH (2012)
Share Paper
